Yahoo Web Search

Search results

    • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 24 minutes ago

      In 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved 4 objective responses; 3 of 4 responses were ongoing for more than 7 months and progression free